Montelukast Sodium Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2020 - 2025

Report Code: HCR 35774 Report Format: PDF + Excel (Delivery in 48 Hrs)
Montelukast Sodium Market size is forecast to reach $856 million by 2025, growing at a CAGR of 7.2% during the forecast period 2020-2025. Montelukast Sodium is used to treat asthma and seasonal year-round allergies. An increasing number of asthma patients and increasing prevalence of seasonal allergies also known as seasonal allergic rhinitis or hay fever are the major factors driving the growth of the market. The rise in respiratory diseases coupled with the growing geriatric population is set to further enhance the overall market demand of Montelukast Sodium during the forecast period 2020-2025. 

Report Coverage
The report: “Montelukast Sodium Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Montelukast Sodium Market. 

By Product Type: Montelukast Sodium Amorphous, and Montelukast Sodium Crystalline
By Dosage Form: Tablet, Chewable Tablet, and Oral Solution
By Applications: Asthma, Allergic Rhinitis, Urticaria, and Others
By Geography: North America, Europe, Asia Pacific and Rest of the World (RoW)

Key Takeaways
  • North America dominated the Montelukast Sodium Market in 2019 owing to the high prevalence of asthma and other respiratory diseases. The Montelukast Sodium Market scope for different regions will be provided in the final report.
  • Increasing prevalence of allergic diseases and its usage to prevent bronchospasm is likely to aid in the market growth of montelukast sodium.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Montelukast Sodium Market report.
  • Lack of awareness among people and increasing side effects such as stomach pain, heartburn, nausea, and diarrhea is poised to create hurdles for the Montelukast Sodium Market.

Product- Segment Analysis
Montelukast Sodium Amorphous segment held the largest share in the Montelukast Sodium Market in 2019 and is estimated to grow at a CAGR of 6.31% during the forecast period 2020-2025. Montelukast Sodium Amorphous is prepared by a solution of montelukast free acid in an aromatic solvent, converting the free acid to an alkali salt using methanolic sodium hydroxide, adding a hydrocarbon solvent and isolating it. Montelukast Sodium is used to prevent exercise-induced bronchoconstriction that occurs when the airways in the lungs narrow during or after exercise causing shortness of breath, wheezing, or cough. Montelukast belongs to a category of medicine called leukotriene receptor antagonists. The Montelukast Sodium Amorphous is set to be the highest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025 owing to its usage as an anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agent.

Application - Segment Analysis
Allergic Rhinitis segment held the largest share in the Montelukast Sodium Market in 2019. Allergic Rhinitis is also known as hay fever which is a type of inflammation in the nose. It is typically triggered by environmental allergens such as pollen, pet hair, dust, or mold. Inherited genetics and environmental exposures contribute to the development of allergies. Urticarial, also known as hives is an outbreak of swollen, pale red bumps or plaques on the skin that appear suddenly - either as a result of the body's reaction to certain allergens or for unknown reasons. It usually causes itching, but also burn or sting. In patients with angioedema predominant chronic spontaneous urticarial, the addition of the leukotriene receptor antagonist montelukast to background daily antihistamine therapy was done to improve symptoms in a significant proportion of individuals. The Allergic Rhinitis segment is set to be the highest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025.

Geography - Segment Analysis
North America dominated the montelukast sodium market in 2019 with a share of more than 36.7%, followed by Europe owing to the high prevalence of asthma and other respiratory diseases. Increasing patients of bronchospasm & primary dysmenorrhea and its usage to prevent wheezing, chest tightness and coughing are increasing the growth of the montelukast sodium market in this region.

However, Europe is estimated to grow at a higher CAGR during the forecast period 2020-2025 owing to a rise in respiratory diseases, increasing patient pool, increasing disposable revenue, and technological advancements. An increasing number of asthma patients are increasing the growth of the montelukast sodium market in this region.

Drivers – Montelukast Sodium Market    
  • Rising respiratory diseases and increasing geriatric population
Rising respiratory diseases and increasing geriatric population is increasing the growth of the montelukast sodium market. Montelukast sodium is clinically effective in treating virus-related wheezing and clinical application and can effectively relieve the symptoms of wheezing, improve lung function, and reduce the incidence rate of infantile asthma. It is generally less preferred for this use than inhaled corticosteroids and is not useful for acute asthma attacks. Other uses include allergic rhinitis and hives of a long duration. Thus, increasing the growth of the montelukast sodium market during the forecast period 2020-2025.
  • Increasing prevalence of allergic diseases and rapidly increasing urbanization
Increasing the prevalence of allergic diseases and rapidly increasing urbanization is increasing the growth of the montelukast sodium market. Montelukast Sodium is used to prevent allergic reactions and asthma flareups during the administration of intravenous immunoglobulin. It is used as an adjunct therapy in the symptomatic treatment of mastocytosis. Montelukast sodium oral granules are indicated for the relief of symptoms of seasonal rhinitis in patients. Thus, increasing the growth of the montelukast sodium market during the forecast period 2020-2025.

Challenges – Montelukast Sodium Market     
  • Lack of awareness among people and increasing side affects 
Some of the factors that can impede the growth of the montelukast sodium   market are Lack of awareness among people and increasing side effects such as stomach pain, heartburn, nausea, and diarrhea.

Montelukast Sodium   Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Montelukast Sodium Market. In 2019, Montelukast Sodium Market share is consolidated by the top ten players present in the market. Montelukast Sodium, the top 10 companies are Apotex Corp, Glenmark Generic Ltd, Kudco Ireland Ltd, Merck Sharp Dohme Corp, Morepen Laboratory, Mylan N V, Roxane Laboratories, Inc, Sandoz International, Teva Pharmaceutical Industry Ltd, and Vintage Pharmaceutical Inc among others.

Acquisitions/Product Launches
  • In February 2019, Sandoz International acquired Aspen Global Incorporated.
  • In August 2016, Teva Pharmaceutical Industry Ltd   acquires Actavis Generics.
1. Montelukast Sodium Market  - Overview
    1.1 Definitions and Scope
2. Montelukast Sodium Market  - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by Dosage Form
    2.4 Key trends by Geography
3. Montelukast Sodium Market  – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Montelukast Sodium Market  - Startup Companies Scenario (Premium)
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Montelukast Sodium Market  – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Montelukast Sodium Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Montelukast Sodium Market  – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Montelukast Sodium Market  – By Product Type (Market Size –$Million/$Billion)
    8.1 Montelukast Sodium Amorphous
    8.2 Montelukast Sodium Crystalline
9. Montelukast Sodium Market  – By Dosage Form(Market Size –$Million/$Billion)
    9.1 Tablet
    9.2 Chewable Tablet
    9.3 Oral Solution
10. Montelukast Sodium Market  – By Application (Market Size –$Million/$Billion)
    10.1 Asthma
    10.2 Allergic Rhintis
    10.3 Urticaria
    10.4 Others
11. Montelukast Sodium Market  - By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia
        11.3.6 New Zealand
        11.3.7 Rest of APAC
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. Montelukast Sodium Market  - Entropy
13. Montelukast Sodium Market  – Industry/Segment Competition Landscape   (Premium) 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Montelukast Sodium Market  – Key Company List by Country Premium (Premium)
15. Montelukast Sodium Market  Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10 and more
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Montelukast Sodium Market, By Product Type Market 2019-2024 ($M)
1.1 Montelukast Sodium Amorphous Market 2019-2024 ($M) - Global Industry Research
1.2 Montelukast Sodium Crystalline Market 2019-2024 ($M) - Global Industry Research
2.Global Montelukast Sodium Market, By Dosage Form Market 2019-2024 ($M)
2.1 Tablet Market 2019-2024 ($M) - Global Industry Research
2.2 Chewable Tablet Market 2019-2024 ($M) - Global Industry Research
2.3 Oral Solution Market 2019-2024 ($M) - Global Industry Research
3.Global Montelukast Sodium Market, By Product Type Market 2019-2024 (Volume/Units)
3.1 Montelukast Sodium Amorphous Market 2019-2024 (Volume/Units) - Global Industry Research
3.2 Montelukast Sodium Crystalline Market 2019-2024 (Volume/Units) - Global Industry Research
4.Global Montelukast Sodium Market, By Dosage Form Market 2019-2024 (Volume/Units)
4.1 Tablet Market 2019-2024 (Volume/Units) - Global Industry Research
4.2 Chewable Tablet Market 2019-2024 (Volume/Units) - Global Industry Research
4.3 Oral Solution Market 2019-2024 (Volume/Units) - Global Industry Research
5.North America Montelukast Sodium Market, By Product Type Market 2019-2024 ($M)
5.1 Montelukast Sodium Amorphous Market 2019-2024 ($M) - Regional Industry Research
5.2 Montelukast Sodium Crystalline Market 2019-2024 ($M) - Regional Industry Research
6.North America Montelukast Sodium Market, By Dosage Form Market 2019-2024 ($M)
6.1 Tablet Market 2019-2024 ($M) - Regional Industry Research
6.2 Chewable Tablet Market 2019-2024 ($M) - Regional Industry Research
6.3 Oral Solution Market 2019-2024 ($M) - Regional Industry Research
7.South America Montelukast Sodium Market, By Product Type Market 2019-2024 ($M)
7.1 Montelukast Sodium Amorphous Market 2019-2024 ($M) - Regional Industry Research
7.2 Montelukast Sodium Crystalline Market 2019-2024 ($M) - Regional Industry Research
8.South America Montelukast Sodium Market, By Dosage Form Market 2019-2024 ($M)
8.1 Tablet Market 2019-2024 ($M) - Regional Industry Research
8.2 Chewable Tablet Market 2019-2024 ($M) - Regional Industry Research
8.3 Oral Solution Market 2019-2024 ($M) - Regional Industry Research
9.Europe Montelukast Sodium Market, By Product Type Market 2019-2024 ($M)
9.1 Montelukast Sodium Amorphous Market 2019-2024 ($M) - Regional Industry Research
9.2 Montelukast Sodium Crystalline Market 2019-2024 ($M) - Regional Industry Research
10.Europe Montelukast Sodium Market, By Dosage Form Market 2019-2024 ($M)
10.1 Tablet Market 2019-2024 ($M) - Regional Industry Research
10.2 Chewable Tablet Market 2019-2024 ($M) - Regional Industry Research
10.3 Oral Solution Market 2019-2024 ($M) - Regional Industry Research
11.APAC Montelukast Sodium Market, By Product Type Market 2019-2024 ($M)
11.1 Montelukast Sodium Amorphous Market 2019-2024 ($M) - Regional Industry Research
11.2 Montelukast Sodium Crystalline Market 2019-2024 ($M) - Regional Industry Research
12.APAC Montelukast Sodium Market, By Dosage Form Market 2019-2024 ($M)
12.1 Tablet Market 2019-2024 ($M) - Regional Industry Research
12.2 Chewable Tablet Market 2019-2024 ($M) - Regional Industry Research
12.3 Oral Solution Market 2019-2024 ($M) - Regional Industry Research
13.MENA Montelukast Sodium Market, By Product Type Market 2019-2024 ($M)
13.1 Montelukast Sodium Amorphous Market 2019-2024 ($M) - Regional Industry Research
13.2 Montelukast Sodium Crystalline Market 2019-2024 ($M) - Regional Industry Research
14.MENA Montelukast Sodium Market, By Dosage Form Market 2019-2024 ($M)
14.1 Tablet Market 2019-2024 ($M) - Regional Industry Research
14.2 Chewable Tablet Market 2019-2024 ($M) - Regional Industry Research
14.3 Oral Solution Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Montelukast Sodium Market Revenue, 2019-2024 ($M)
2.Canada Montelukast Sodium Market Revenue, 2019-2024 ($M)
3.Mexico Montelukast Sodium Market Revenue, 2019-2024 ($M)
4.Brazil Montelukast Sodium Market Revenue, 2019-2024 ($M)
5.Argentina Montelukast Sodium Market Revenue, 2019-2024 ($M)
6.Peru Montelukast Sodium Market Revenue, 2019-2024 ($M)
7.Colombia Montelukast Sodium Market Revenue, 2019-2024 ($M)
8.Chile Montelukast Sodium Market Revenue, 2019-2024 ($M)
9.Rest of South America Montelukast Sodium Market Revenue, 2019-2024 ($M)
10.UK Montelukast Sodium Market Revenue, 2019-2024 ($M)
11.Germany Montelukast Sodium Market Revenue, 2019-2024 ($M)
12.France Montelukast Sodium Market Revenue, 2019-2024 ($M)
13.Italy Montelukast Sodium Market Revenue, 2019-2024 ($M)
14.Spain Montelukast Sodium Market Revenue, 2019-2024 ($M)
15.Rest of Europe Montelukast Sodium Market Revenue, 2019-2024 ($M)
16.China Montelukast Sodium Market Revenue, 2019-2024 ($M)
17.India Montelukast Sodium Market Revenue, 2019-2024 ($M)
18.Japan Montelukast Sodium Market Revenue, 2019-2024 ($M)
19.South Korea Montelukast Sodium Market Revenue, 2019-2024 ($M)
20.South Africa Montelukast Sodium Market Revenue, 2019-2024 ($M)
21.North America Montelukast Sodium By Application
22.South America Montelukast Sodium By Application
23.Europe Montelukast Sodium By Application
24.APAC Montelukast Sodium By Application
25.MENA Montelukast Sodium By Application
26.Merck Sharp Dohme Corp, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Morepen Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Teva Pharmaceutical Industry Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Mylan N V, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Roxane Laboratories, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Glenmark Generic Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Sandoz International Gmbh, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Vintage Pharmaceutical Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Kudco Ireland Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Apotex Corp, Sales /Revenue, 2015-2018 ($Mn/$Bn)